C07C 235/20
Having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms
Official title: having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
C07C235/20 (Having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms) appears on 238 US grants and 252 published applications in this corpus.
Search patents in C07C- Granted patents
- 238
- Published applications
- 252
- Assignees
- 156
- Inventors
- 749
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 2 | 0 |
| 1992 | 3 | 0 |
| 1993 | 5 | 0 |
| 1994 | 0 | 0 |
| 1995 | 4 | 0 |
| 1996 | 3 | 0 |
| 1997 | 3 | 0 |
| 1998 | 7 | 0 |
| 1999 | 5 | 0 |
| 2000 | 3 | 0 |
| 2001 | 4 | 2 |
| 2002 | 17 | 8 |
| 2003 | 7 | 16 |
| 2004 | 14 | 5 |
| 2005 | 3 | 12 |
| 2006 | 4 | 18 |
| 2007 | 10 | 7 |
| 2008 | 6 | 8 |
| 2009 | 9 | 11 |
| 2010 | 5 | 8 |
| 2011 | 5 | 12 |
| 2012 | 8 | 8 |
| 2013 | 10 | 7 |
| 2014 | 8 | 13 |
| 2015 | 4 | 11 |
| 2016 | 12 | 11 |
| 2017 | 9 | 12 |
| 2018 | 8 | 7 |
| 2019 | 5 | 10 |
| 2020 | 13 | 14 |
| 2021 | 8 | 10 |
| 2022 | 9 | 7 |
| 2023 | 9 | 13 |
| 2024 | 5 | 12 |
| 2025 | 7 | 7 |
| 2026 | 3 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Capsaicin analogs and uses thereof29 Sep 2026US 12,747,200 B2Young BioPharma, LLC
- Isotopic thyromimetic compounds22 Sep 2026US 12,741,932 B2Autobahn Therapeutics, Inc.
- Fatty acid amide hydrolase (FAAH) cleavable prodrugs of thyromimetics and combination with peripherally restricted FAAH inhibitors26 May 2026US 12,637,413 B2Autobahn Therapeutics, Inc.
- Compounds advantageous in the treatment of central nervous system diseases and disorders2 Dec 2025US 12,486,218 B2Aurimmed Pharma, Inc.
- CB1R receptor blockers with acyclic backbones18 Nov 2025US 12,473,270 B2Yissum Research Development Company of the Hebrew University of Imersualem Ltd.
- Methods and materials for increasing level of phosphorylated ampk protein21 May 2026US 2026/0138955 A1University of Pittsburgh—Of the Commonwealth System of Higher Education
- Compositions and methods for treating cancer26 Mar 2026US 2026/0085074 A1The Regents of the University of California
- Prostacyclin compounds, compositions and methods of use thereof26 Feb 2026US 2026/0055047 A1Insmed Incorporated
- Cb1r receptor blockers with acyclic backbones11 Dec 2025US 2025/0376460 A1Yissum Research Development Company of the Hebrew University of Jerusalem
- Series of Compounds for Treatment of Skin Diseases and Other Conditions27 Nov 2025US 2025/0361197 A1Unigen, Inc.
Most cited
By later US patents
- N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives56US 7,176,242 B2Elan Pharmaceuticals, Inc. · 2007
- Prostacyclin compounds, compositions and methods of use thereof48US 9,255,064 B2Insmed Incorporated · 2016
- Prostacyclin compounds, compositions and methods of use thereof40US 9,469,600 B2Insmed Incorporated · 2016
- Substituted amides39US 6,972,295 B2Merck & Co., Inc. · 2005
- Treprostinil derivative compounds and methods of using same38US 9,505,737 B2Corsair Pharma, Inc. · 2016